The UK’s Film Distributors’ Association (FDA) has appointed Andy Leyshon as its new Chief Executive, succeeding Mark Batey who has held the post for two decades.
Previously, Andy Leyshon was Managing Director UK & Ireland of STX International. He has also recently been serving as a distribution consultant for Gower Street Analytics, working with clients across the film industry. Before STX, Leyshon spent ten years as Sales Director of Universal Pictures UK & Eire. He also served as Sales Director of Momentum Pictures.
Andy Leyshon will step into his role in September.
FDA President Lord Puttnam said:
“This is an enormously important appointment for FDA. As Andy knows better than most, film is an influential, dynamic part of the UK’s growing creative economy, yet it comes at a time when the business is facing unprecedented challenges as consumption patterns ever more rapidly evolve.”
Andy Leyshon said:
“I’m very excited to be joining FDA at what is a busy time on so many strategic and policy fronts. Distribution is the beating heart of the UK film industry and FDA is a vital, potent voice in shaping the sector’s successful future path. We have a wonderfully diverse membership and it will be an honour to work with and represent them over the coming years.”
Outgoing CEO Mark Batey, said:
“I could not be happier to be handing over the reins of FDA to Andy Leyshon. He is one of the UK’s most experienced and passionate film distribution professionals and will prove a terrific asset.”